Jagsonpal Pharmaceuticals Allots 296,320 Equity Shares Under ESOP Plan; Paid-up Capital Increases
Jagsonpal Pharmaceuticals Limited announced the allotment of equity shares under its Employee Stock Option Plan (ESOP). The move increased the company's paid-up share capital following the exercise of vested options by eligible employees.The Nomination and Remuneration Committee issued and allotted 296,320 Equity Shares to the Company's eligible employees under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022 (JPL ESOP 2022). These new shares carry a par value of Rs. 2/- each and shall rank pari-passu with all existing equity shares of the company.
The allotment resulted in an increase in the paid-up share capital. Prior to the issuance, the paid up share capital stood at Rs. 13,10,78,300, which comprised 6,55,39,150 equity shares of Rs. 2/- each. Following the allotment, the total paid-up share capital increased to Rs. 13,16,70,940.
Key financial details regarding this transaction are presented below:
| Metric | Previous Status | Transaction Details | Post-Transaction Status |
|---|---|---|---|
| Allotted Shares (under JPL ESOP 2022) | N/A | 296,320 Equity Shares | N/A |
| Old Paid-up Capital | Rs. 13,10,78,300 | Share Par Value: Rs. 2/- | Rs. 13,16,70,940 |
| Existing Total Issued Shares | 6,55,39,150 | Shares issued in ESOP | 6,58,35,470 |
The details provided confirm that the new shares are identical to existing shares and have been allotted as part of the established Employee Stock Option Plan.
JAGSNPHARM Stock Price Movement
Today, shares of Jagsonpal Pharmaceuticals Limited edged higher to close at ₹203.45, gaining 1.99%. The stock traded on a volume of 46,597 shares and finished strong after testing the day's high of ₹206.05.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.